Mesothelioma Lawyers News service: Personal injury attorneys specializing in asbestos lung cancer litigation in: Boston, Chicago, Dallas, Denver, Detroit, Hollywood, Houston, Indianapolis, Los Angeles, New York, San Francisco
 
Nonprofit Executives Plead Not Guilty in Asbestos Exposure Case
July 18, 2010 | Read the story >>

Cancer concerns about back pain device

2010-07-26 13:39:45 (GMT) (mesotheliomacancernews.com - Cancer News)

Print & Social Options


07/26/2010 // US // Get Cancer Answers // News Desk

Washington – A device used for the treatment of lower back pain has sparked concern from U.S. reviewers due to a number of cancer cases linked to patients who have used the device. As reported by Reuters, an evaluation of the experimental Medtronic Inc spinal fusion device, Amplify, is set to be carried out by a Food and Drug Administration advisory panel Tuesday due to safety concerns.

FDA reviewers are quoted in the report as stating in a summary for the advisory panel, “The primary safety concern is the increased numbers of cancer events in patients treated with Amplify compared to the control group.”

Medtronic has reportedly stated that a “plausible biological mechanism” has not been found to show the device contributes to the development of cancer.

The latest in Cancer News



Media Information:

Address:
Phone: 000-000-0000
Url: http://getcanceranswers.org/cancer-concerns-about-back-pain-device_1556.html

Online Cancer News Legal News Distribution - mesotheliomacancernews.com

 

Mesothelioma News Portal covering News on Mesothelioma: MesotheliomaCancerNews.com offer s complete news articles, press rereleases by Mesothelioma lawyers and asbestos attorneys including heath related topics on cancer associated to Mesothelioma including diagnosis, treatment, coping, asbestos disease and financial assistance.

News for attorneys, lawyers, cancer treatment centers in: Boston, Chicago, Dallas, Denver, Detroit, Hollywood, Houston, Indianapolis, Los Angeles, New York, San Francisco

Educational Topics: Cancer Prognosis| Mesothelioma Lung Cancer